Urotide Investment Limited was linked in court to an alleged tax fraud case involving the use of fictitious invoices. Prosecutors accused the company’s director, Peterson Maina Waruhiu, of making false income tax statements relating to the 2022 and 2023 tax years.
According to the prosecution, the alleged scheme involved claiming fictitious purchases from four companies in order to reduce Urotide Investment Limited’s tax obligations. The disputed transactions were said to have been used to fraudulently lower the company’s Value Added Tax liabilities, with the reported amount involved standing at approximately KSh 125.4 million.
The allegations against Urotide Investment Limited and Peterson Maina Waruhiu were reported in connection with court proceedings and should not be treated as a final finding of guilt. The matter remains subject to the judicial process, and the accused are presumed innocent unless and until proven guilty in court.
Reported 29 Apr 2026
